About Hospital Universitario Miguel Servet; Servicio Oncologia
El Hospital Universitario Miguel Servet, también conocido como "El Servet" o la "Casa Grande" de Zaragoza, es un hospital público situado en el Paseo de Isabel La Católica, en Zaragoza, España. Se trata del principal centro sanitario de Aragón.
Clinical Trials at Hospital Universitario Miguel Servet; Servicio Oncologia
During the past decade, Hospital Universitario Miguel Servet; Servicio Oncologia conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 23 clinical trials were completed, i.e. on
average, 115% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Miguel Servet; Servicio Oncologia"
#1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Hospital Universitario Miguel Servet; Servicio Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Miguel Servet; Servicio Oncologia" are
"Breast Cancer" (10 trials), "Non-Squamous Non-Small Cell Lung Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Breast Neoplasms" (2 trials) and "Carcinoma, Hepatocellular" (2 trials). Many other conditions were trialed in "Hospital Universitario Miguel Servet; Servicio Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Miguel Servet; Servicio Oncologia
Most popular intervention types in "Hospital Universitario Miguel Servet; Servicio Oncologia" are "Drug" (34 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (15 trials), "Docetaxel" (11 trials), "Pertuzumab" (10 trials), "Bevacizumab" (8 trials) and "Trastuzumab" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Miguel Servet; Servicio Oncologia
The vast majority of trials in "Hospital Universitario Miguel Servet; Servicio Oncologia" are
28 trials for "All" genders and 8 trials for "Female" genders.
Clinical Trials Status at Hospital Universitario Miguel Servet; Servicio Oncologia
Currently, there are NaN active trials in "Hospital Universitario Miguel Servet; Servicio Oncologia".
undefined are not yet recruiting,
6 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Hospital Universitario Miguel Servet; Servicio Oncologia,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Miguel Servet; Servicio Oncologia, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".